Skip to main content

Advertisement

Log in

Successful Treatment of Canine Sporotrichosis with Terbinafine: Case Reports and Literature Review

  • Original Paper
  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Sporotrichosis occurs worldwide, and the metropolitan region of Rio de Janeiro, Brazil, is a main endemic area, with a large number of human and animal cases in the last 19 years. This mycosis is more frequently described in cats rather than in dogs. There are a limited number of oral antifungal agents for the treatment of sporotrichosis in animals. In this context, the effectiveness of terbinafine in the treatment of sporotrichosis in humans, as well as the promising results of in vitro susceptibility tests, inspired us to use this drug in the therapy of this mycosis in dogs. We reported for the first time the use of terbinafine in the treatment of two dogs with sporotrichosis caused by Sporothrix brasiliensis. Moreover, we provided an overview of therapeutic features of canine sporotrichosis cases reported since the 1960s. One of the dogs presented the fixed cutaneous form of the disease, while the other patient presented hyperemia of the nasal mucosa and respiratory signs only. Terbinafine showed high antifungal activity in vitro against the canine Sporothrix isolates. The dogs were successfully treated with terbinafine, with remission of all clinical signs initially presented. The current reports indicate that this drug can emerge as a therapeutic option for canine sporotrichosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rodrigues AM, de Melo Teixeira M, de Hoog GS, Schubach TM, Pereira SA, Fernandes GF, et al. Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline sporotrichosis outbreaks. PLoS Negl Trop Dis. 2013;7(6):e2281. https://doi.org/10.1371/journal.pntd.0002281.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Silva MBT, Costa MMM, Torres CCS, Gutierrez-Galhardo MC, Valle ACF, de Magalhães MAFM, et al. Urban sporotrichosis: a neglected epidemic in Rio de Janeiro, Brazil. Cad Saude Publica. 2012;28(10):1867–80.

    Article  PubMed  Google Scholar 

  3. Gremião IDF, Miranda LHM, Reis EG, Rodrigues AM, Pereira AS. Zoonotic epidemic of sporotrichosis: cat to human transmission. PLoS Pathog. 2017. https://doi.org/10.1371/journal.ppat.1006077.

    PubMed  PubMed Central  Google Scholar 

  4. Oliveira MM, Almeida-Paes R, Muniz MM, Gutierrez-Galhardo MC, Zancope-Oliveira RM. Phenotypic and molecular identification of Sporothrix isolates from an epidemic area of sporotrichosis in Brazil. Mycopathologia. 2011;172(4):257–67. https://doi.org/10.1007/s11046-011-9437-3.

    Article  PubMed  Google Scholar 

  5. Meyer KKF. The relation of animal to human sporotrichosis studies on American sporotrichosis. JAMA. 1915;LXV(7):579–85.

    Article  Google Scholar 

  6. Schubach TM, Schubach A, Okamoto T, Barros MB, Figueiredo FB, Cuzzi T, et al. Canine sporotrichosis in Rio de Janeiro, Brazil: clinical presentation, laboratory diagnosis and therapeutic response in 44 cases (1998–2003). Med Mycol. 2006;44(1):87–92.

    Article  PubMed  Google Scholar 

  7. Cafarchia C, Sasaneli M, Lia RP, Caprariis D, Guillot J, Otranto D. Lymphocutaneous and nasal sporotrichosis in a dog from southern Italy: case report. Mycopathologia. 2007;163:75–9.

    Article  PubMed  Google Scholar 

  8. Whittemore JC, Webb CB. Successful treatment of nasal sporotrichosis in dog. Can Vet J. 2007;48(4):411–4.

    PubMed  PubMed Central  Google Scholar 

  9. Crothers SL, White SD, Ihrke PJ, Affolter VK. Sporotrichosis: a retrospective evaluation of 23 cases seen in northern California (1987–2007). Vet Dermatol. 2009;20(4):249–59.

    Article  PubMed  Google Scholar 

  10. Rosser E, Dunstan R. Sporotrichosis. In: Greene CE, editor. Infectious diseases of the dog and cat. 3rd ed. Philadelphia: Saunders Elsevier; 2006. p. 608–12.

    Google Scholar 

  11. Schubach TM, Menezes RC, Wanke B. Sporotrichosis. In: Greene EC, editor. Infectious diseases of the dog and cats. 4th ed. Missouri: Elsevier; 2012. p. 645–50.

    Google Scholar 

  12. Pereira SA, Gremião IDF, Menezes RC. Sporotrichosis in animals: zoonotic transmission. In: Carlos IZ, editor. Sporotrichosis new developments and future prospects. Berlin: Springer; 2015. p. 83–102.

    Google Scholar 

  13. Sykes JE, Torres SM, Armstrong PJ, Lindeman CJ. Itraconazole for treatment of sporotrichosis in a dog residing on a Christmas tree farm. J Am Vet. Med Assoc. 2001;218(9):1440-3, 1421.

  14. Farias MR, Assunção DL, Duarte G, Vandresen G, Werner J, Tarqeti U. Canine bone sporotrichosis: a case report. Sem Cienc Agrar. 2015;36(3):1445–50.

    Article  Google Scholar 

  15. Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126(Suppl 39):2–7.

    Article  PubMed  Google Scholar 

  16. Gupta AK, Lynde CW, Lauzin GJ, et al. Cutaneous adverse effects associated with terbinafine therapy: 10 cases reports and a review of the literature. Br J Dermatol. 1998;138:529–32.

    Article  CAS  PubMed  Google Scholar 

  17. Esterre P, Inzan CK, Ramarcel ER, Andriantsimahavandy A, Ratsioharana M, Pecarrere JL, et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol. 1996;134(Suppl 46):33–6.

    Article  PubMed  Google Scholar 

  18. Silva-Rocha WP, Cardoso FJ, Colalto W, Melo AS, Chaves GM. Clinical improvement of chromoblastomycosis refractory to itraconazole successfully treated with high dose of terbinafine. J Dermatol. 2013;40(9):775–6.

    Article  CAS  PubMed  Google Scholar 

  19. Moriello KA. Treatment of dermatophytosis in dogs and cats: review of published studies. Vet Dermatol. 2004;15:99–107.

    Article  PubMed  Google Scholar 

  20. Rosales MS, Marsella R, Kunkle G, et al. Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs—a pilot study. Vet Dermatol. 2005;16:171–6.

    Article  PubMed  Google Scholar 

  21. Francesconi G, Valle AC, Passos S, Reis R, Galhardo MC. Terbinafine (250 mg/day): effective and safe treatment of cutaneous sporotrichosis. J Eur Acad Dermatol Venereol. 2009;23(11):1273–6.

    Article  CAS  PubMed  Google Scholar 

  22. Francesconi G, Francesconi do Valle AC, Passos SL, Lima Barros MB, Almeida-Paes R, Curi AL, et al. Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. Mycopathologia. 2011;171(5):349–54.

    Article  CAS  PubMed  Google Scholar 

  23. Meinerz AR, Nascente OS, Schuch LFD, Cleff MB, Santin R, Brun CS, et al. In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole. Rev Soc Bras Trop. 2007;40(1):60–2.

    Article  Google Scholar 

  24. Gutierrez-Galhardo MC, Oliveira RMZ, Valle ACF, Almeida Paes R, Silvatavares PM, Monzon A, et al. Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil. Med Mycol. 2008;46:141–51.

    Article  Google Scholar 

  25. Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R, Camargo ZP, et al. Susceptibilidade of Sporothrix brasiliensis isolates to anphotericin B, azoles and terbinafine. Med Mycol. 2015;53(2):178–88.

    Article  CAS  PubMed  Google Scholar 

  26. Oliveira de Oliveira MM, Sampaio P, Almeida-Paes R, Pais C, Gutierrez-Galhardo MC, Zancope-Oliveira RM. Rapid identification of Sporothrix species by T3B fingerprinting. J Clin Microbiol. 2012;50(6):2159–62. https://doi.org/10.1128/JCM.00450-12.

    Article  Google Scholar 

  27. Oliveira MM, Franco-Duarte R, Romeo O, Pais C, Criseo G, Sampaio P, Zancope-Oliveira RM. Evaluation of T3B fingerprinting for identification of clinical and environmental Sporothrix species. FEMS Microbiol Lett. 2015;362(6):pii: fnv027. https://doi.org/10.1093/femsle/fnv027.

    Article  Google Scholar 

  28. Clinical and Laboratory Standards Institute (CLSI). 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 2nd ed Approved standard M38-A2. Clincal and Laboratory Standards Institute, Wayne, PA.

  29. Migliano MF, de Freitas DC, Moreno G. Sporotrichosis in dogs. Rev Fac Med Vet S Paulo. 1963;7(1):225–35.

    Article  Google Scholar 

  30. Londero AT, Castro RM, Fischman O. Two cases of sporotrichosis in dogs in Brazil. Sabouraudia. 1964;3(4):273–4.

    Article  CAS  PubMed  Google Scholar 

  31. Freitas D, Moreno G, Saliba A, Bottino J, Mós E. Sporotrichosis in dogs and cats. Rev Fac Med Vet S Paulo. 1965;7(2):381–7.

    Article  Google Scholar 

  32. Berry JM, Kelley DC, Strafuss AC. Sporotrichosis in a dog: a case report. Vet Med Sm Anim Clin. 1971;66:226–9.

    Google Scholar 

  33. Koehne G, Powell HS, Hail RI. Sporotrichosis in a dog. J Am Vet Med Assoc. 1971;159(7):892–4.

    CAS  PubMed  Google Scholar 

  34. Scott DW, Bentinck-Smith J, Haggerty GF. Sporotrichosis in three dogs. Cornell Vet. 1974;64(416/42):6.

    Google Scholar 

  35. Dion WM, Speckmann G. Canine otitis externa caused by the fungus Sporothrix schenkii. Can Vet J. 1978;19:40–1.

    Google Scholar 

  36. Woodard DC. Splenic sporotrichosis in a dog. Vet Med Small Anim Clin. 1980;75:1011–2.

    CAS  PubMed  Google Scholar 

  37. Goad DL, Goad ME. Osteoarticular sporotrichosis in a dog. J Am Vet Med Assoc. 1986;189:1326–8.

    CAS  PubMed  Google Scholar 

  38. Iwasaki M, Hagiwara MK. Skeletal sporotrichosis. Companion Anim Pract. 1988;2:27–31.

    Google Scholar 

  39. Moriello KA, Franks P, Lewis DD, King R. Cutaneous-lymphatic and nasal sporotrichosis in a dog. J Am Anim Hosp Assoc. 1988;24:621–6.

    Google Scholar 

  40. Sanford SE. Persistent sporotrichosis in a dog. Can Vet J. 1992;33:826.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Bernstein JÁ, Cook HE, Gill AF, Ryan KA, Sirninger J. Cytologic diagnosis of generalized cutaneous sporotrichosis in a hunting hound. Vet Clin Pathol. 2007;36(1):94–6.

    Article  PubMed  Google Scholar 

  42. Madrid IM, Xavier MO, Mattei AS, Carapeto LP, Antunes TA, Júnior RS, Nobre MO, Meireles MCA. Canine sporotrichosis: report of three cases. Braz J Vet Res Anim Sci. 2007;44(6):441–3.

    Article  Google Scholar 

  43. Filgueira KD. Sporotrichosis in the canine species: a case report on city of Mossoro, RN. Cienc Anim Bras. 2009;10(2):673–7.

    Google Scholar 

  44. Grassani MH, Juppa ALC, da Silva DA, Figueiredo FB. Use of potassium iodide in the treatment os sporotrichosis in dog after failure treatment with ketoconazole and itraconazole—a case report. Clin Vet. 2012;101:116–20.

    Google Scholar 

  45. Rossi CN, Odaguiri J, Larsson CE. Retrospective assessment of the treatment of sporotrichosis in cats and dogs using itraconazole. Acta Sci Vet. 2013;41:1112.

    Google Scholar 

  46. Guterres KA, Matos CB, Osório LG, Schuch ID, Cleff MB. The use of (1-3) β-glucan along with itraconazole against canine refractory sporotrichosis. Mycopathologia. 2014;177(3–4):217–21.

    CAS  PubMed  Google Scholar 

  47. Kohler LM, Monteiro PC, Hahn RC, Hamdan JS. In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine. J Clin Microbiol. 2004;42(9):4319–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Rodrigues AM, de Hoog GS, de Cássia Pires D, Brihante RS, Sidrim JJ, Gadelha MF, Colombo AL, de Camargo ZP. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. BMC Infect Dis. 2014;14:219. https://doi.org/10.1186/1471-2334-14-219.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Almeida-Paes R, Brito-Santos F, Figueiredo-Carvalho MHG, Machado ACS, Oliveira MME, Pereira SA, Gutierrez-Galhardo MC, Zancopé-Oliveira RM. Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis. Mem Inst Oswaldo Cruz. 2017;112(5):376–81. https://doi.org/10.1590/0074-02760160527.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Sanchotene KO, Brandolt TM, Klafke GB, Poester VR, Xavier MO. In vitro susceptibility of Sporothrix brasiliensis: comparison of yeast and mycelial phases. Med Mycol. 2017;55(8):869–76. https://doi.org/10.1093/mmy/myw143.

    Article  PubMed  Google Scholar 

  51. Hull PR, Vismer HF. Treatment of cutaneous sporotrichosis with terbinafine. Br J Dermatol. 1992;126(39):51–5.

    Article  PubMed  Google Scholar 

  52. Kauffman CA, Bustamante B, Chapman SW, Pappas PG. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the infectious diseases society of America. Clin. Infect. Dis. 2007; 15; 45(10):1255-65.

  53. Song Y, Zhong SX, Yao L, Cai Q, Zhou JF, Liu YY, et al. Efficacy and of itraconazole pulses vs. continous regiment in cutaneous sporotrichosis. J Eur Acad Dermatol Venereol. 2011;25(3):302–5.

    Article  CAS  PubMed  Google Scholar 

  54. Heidrich D, Senter L, Valente P, Stopiglia CDO, Vetoratto G, Scroferneker ML. Successful treatment of terbinafine in a case of sporotrichosis. An Bras Dermatol. 2011;86(4 suppl 1):S182–5.

    Article  PubMed  Google Scholar 

  55. Gremião IDF, Menezes RC, Schubach TM, Figueiredo AB, Cavalcanti MC, Pereira SA. Feline sporotrichosis: epidemiological and clinical aspects. Med Mycol. 2015;53:15–21.

    Article  PubMed  Google Scholar 

  56. Pereira SA, Passos SR, Silva JN, Gremiao ID, Figueiredo FB, Teixeira JL, et al. Response to azolic antifungal agents for treating feline sporotrichosis. Vet Rec. 2010;166(10):290–4.

    Article  CAS  PubMed  Google Scholar 

  57. Balda AC, Otsuka M, Larsson CE. A clinical trial using griseofulvin and terbinafine in the treatment of canine and feline dermatophytosis. Cienc Rural. 2007;37(3):750–4.

    Article  CAS  Google Scholar 

  58. Berger DJ, Lewis TP, Schick AE, Stone RT. Comparison of once-daily versus twice-weekly terbinafine administration for the treatment of canine Malassezia dermatitis—a pilot study. Vet Dermatol. 2012;23(5):418-e79. https://doi.org/10.1111/j.1365-3164.2012.01074.x.

    Article  PubMed  Google Scholar 

  59. Freitas DF, Santos SS, Almeida-Paes R, de Oliveira MM, do Valle AC, Gutierrez-Galhardo MC, et al. Increase in virulence of Sporothrix brasiliensis over 5 years in a patient with chronic disseminated sporotrichosis. Virulence. 2015;6(2):112–20. https://doi.org/10.1080/21505594.2015.1014274.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Almeida-Paes R, Figueiredo-Carvalho MHG, Brito-Santos F, Almeida-Silva F, Oliveira MME, Zancompé-Oliveira RM. Melanins protect Sporothrix brasiliensis and Sporothrix schenkii from the antifungal effects of terbinafine. PLoS ONE. 2016;11(3):e0152796. https://doi.org/10.1371/journal.pone.0152796.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are thankful to Tânia Maria Pacheco Schubach for revising the manuscript and for processing figures; to James Czarnecki for the careful English review of the article; and to the staff of Diagnostic Section of the Mycology Laboratory of INI/Fiocruz. This study was supported by Fundação Carlos Chagas de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ—Programa Jovem Cientista do Nosso Estado/E-26/203.303/2016). SAP holds a research productivity fellowship granted by Conselho Nacional de Pesquisa e Desenvolvimento Tecnológico (CNPq). PGV holds a PhD scholarship granted by CNPq.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paula Gonçalves Viana.

Ethics declarations

Conflict of interest

The authors declared no potential conflict of interest with respect to the research, authorship, and/or publication of this article.

Ethical Approval

All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

Informed Consent

The owners gave verbal informed consent for using the following data obtained from their dog and were informed that these data would remain anonymous.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Viana, P.G., Figueiredo, A.B.F., Gremião, I.D.F. et al. Successful Treatment of Canine Sporotrichosis with Terbinafine: Case Reports and Literature Review. Mycopathologia 183, 471–478 (2018). https://doi.org/10.1007/s11046-017-0225-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-017-0225-6

Keywords

Navigation